Back to Journals » Cancer Management and Research » Volume 10

Serum miR-4530 sensitizes breast cancer to neoadjuvant chemotherapy by suppressing RUNX2

Total article views   HTML views PDF downloads Totals
8,114 Dovepress* 7,714+ 725 8,439
PubMed Central* 400 137 537
Totals 8,114 862 8,976
*Since 9 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar